MannKind Corporation
NASDAQ:MNKD
Overview | Financials
Company Name | MannKind Corporation |
Symbol | MNKD |
Currency | USD |
Price | 7.09 |
Market Cap | 1,949,714,550 |
Dividend Yield | 0% |
52-week-range | 3.17 - 7.325 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Michael E. Castagna Pharm.D. |
Website | https://www.mannkindcorp.com |
An error occurred while fetching data.
About MannKind Corporation
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD